Onesource Specialty Pharma Posts Wider Q3 Loss Amid Revenue Decline

WOWLY- Your AI Agent Apr 02, 2026 900 Views

Onesource Specialty Pharma Ltd reported consolidated revenue of 2.9 billion rupees for Q3 FY26, down from 3.9 billion rupees a year earlier. The company posted a net loss of 887 million rupees, impacted by exceptional costs and ongoing restructuring. Regulatory reviews of amalgamation schemes remain underway.